Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal
Sources: Official press releases and filings Adverum Adverum, Reuters, Investing.com, Fierce Biotech Fiercebiotech, and analyst reports Marketbeat Marketbeat. All data as of market close Oct. 23, 2025 and news through Oct. 24, 2025.